TaiGen Biopharmaceuticals Holdings Limited 4157.TWO Stock
TaiGen Biopharmaceuticals Holdings Limited Price Chart
TaiGen Biopharmaceuticals Holdings Limited 4157.TWO Financial and Trading Overview
Contents
- TaiGen Biopharmaceuticals Holdings Limited Price Chart
- TaiGen Biopharmaceuticals Holdings Limited 4157.TWO Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of TaiGen Biopharmaceuticals Holdings Limited
- Q&A For TaiGen Biopharmaceuticals Holdings Limited Stock
| TaiGen Biopharmaceuticals Holdings Limited stock price | 14.8 TWD |
| Previous Close | 15.65 TWD |
| Open | 15.65 TWD |
| Bid | 15.7 TWD x 0 |
| Ask | 15.75 TWD x 0 |
| Day's Range | 15.65 - 15.85 TWD |
| 52 Week Range | 13.45 - 21.05 TWD |
| Volume | 919.51K TWD |
| Avg. Volume | 1.68M TWD |
| Market Cap | 11.29B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0.19 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
4157.TWO Valuation Measures
| Enterprise Value | 11.22B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 11.640798 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
TaiGen Biopharmaceuticals Holdings Limited Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -7.66% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 21.05 TWD |
| 52 Week Low | 13.45 TWD |
| 50-Day Moving Average | 15.22 TWD |
| 200-Day Moving Average | 15.62 TWD |
4157.TWO Share Statistics
| Avg. Volume (3 month) | 1.68M TWD |
| Avg. Daily Volume (10-Days) | 2.95M TWD |
| Shares Outstanding | 716.84M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 35.93% |
| % Held by Institutions | 25.00% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 0.05 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 32.49M TWD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.34 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 1.353 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of TaiGen Biopharmaceuticals Holdings Limited
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 138, Xinming Road |
| ZIP | 11470 |
| Phone | 886 2 8177 7020 |
| Website | https://www.taigenbiotech.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
TaiGen Biopharmaceuticals Holdings Limited, a pharmaceutical company, develops novel therapeutics for transformative diseases worldwide. The company develops Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic for the treatment of bacterial infections. It is also developing Taigexyn for treating community-acquired pneumonia and diabetic foot infection, as well as other bacterial infections; Burixafor, a stem cell mobilizer for stem cell transplantation and chemosenzitization; TG-1000, an influenza antiviral drug for treating influenza A, B, and avian influenza H7N9; and Furaprevir, a hepatitis C virus protease inhibitor for the treatment of chronic hepatitis C. The company was founded in 2001 and is based in Taipei City, Taiwan.
Q&A For TaiGen Biopharmaceuticals Holdings Limited Stock
What is a current 4157.TWO stock price?
TaiGen Biopharmaceuticals Holdings Limited 4157.TWO stock price today per share is 14.8 TWD.
How to purchase TaiGen Biopharmaceuticals Holdings Limited stock?
You can buy 4157.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for TaiGen Biopharmaceuticals Holdings Limited?
The stock symbol or ticker of TaiGen Biopharmaceuticals Holdings Limited is 4157.TWO.
Which industry does the TaiGen Biopharmaceuticals Holdings Limited company belong to?
The TaiGen Biopharmaceuticals Holdings Limited industry is Biotechnology.
How many shares does TaiGen Biopharmaceuticals Holdings Limited have in circulation?
The max supply of TaiGen Biopharmaceuticals Holdings Limited shares is 717.84M.
What is TaiGen Biopharmaceuticals Holdings Limited Price to Earnings Ratio (PE Ratio)?
TaiGen Biopharmaceuticals Holdings Limited PE Ratio is 77.89474000 now.
What was TaiGen Biopharmaceuticals Holdings Limited earnings per share over the trailing 12 months (TTM)?
TaiGen Biopharmaceuticals Holdings Limited EPS is 0.19 TWD over the trailing 12 months.
Which sector does the TaiGen Biopharmaceuticals Holdings Limited company belong to?
The TaiGen Biopharmaceuticals Holdings Limited sector is Healthcare.